Sector Update: Health Care Stocks Edge Higher Premarket Friday

MT Newswires Live12-12

Health care stocks were edging higher premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.6% and the iShares Biotechnology ETF (IBB) up 0.1%.

Relay Therapeutics (RLAY) shares were up more than 11% after the company said interim results from a study of zovegalisib plus fulvestrant to treat breast cancer patients showed "robust activity."

ImmunityBio (IBRX) stock was up more than 4% after the company said the European Medicines Agency has recommended granting a conditional marketing authorization for anktiva in combination with BCG for the treatment of BGC-unresponsive non-muscle invasive bladder cancer.

BioCryst Pharmaceuticals (BCRX) shares were up more than 2% after the company said the US Food and Drug Administration approved Orladeyo oral pellets to help prevent hereditary angioedema attacks in children ages 2 to under 12.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590047895?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-12 22:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590047895","market":"sg","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Edge Higher Premarket Friday","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were edging higher premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.6% and the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) up 0.1%.</p><p><a href=\"https://laohu8.com/S/RLAY\">Relay Therapeutics</a> (RLAY) shares were up more than 11% after the company said interim results from a study of zovegalisib plus fulvestrant to treat breast cancer patients showed \"robust activity.\"</p><p>ImmunityBio (IBRX) stock was up more than 4% after the company said the European Medicines Agency has recommended granting a conditional marketing authorization for anktiva in combination with BCG for the treatment of BGC-unresponsive non-muscle invasive bladder cancer.</p><p>BioCryst Pharmaceuticals (BCRX) shares were up more than 2% after the company said the US Food and Drug Administration approved Orladeyo oral pellets to help prevent hereditary angioedema attacks in children ages 2 to under 12.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Edge Higher Premarket Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Edge Higher Premarket Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-12 22:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks were edging higher premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.6% and the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) up 0.1%.</p><p><a href=\"https://laohu8.com/S/RLAY\">Relay Therapeutics</a> (RLAY) shares were up more than 11% after the company said interim results from a study of zovegalisib plus fulvestrant to treat breast cancer patients showed \"robust activity.\"</p><p>ImmunityBio (IBRX) stock was up more than 4% after the company said the European Medicines Agency has recommended granting a conditional marketing authorization for anktiva in combination with BCG for the treatment of BGC-unresponsive non-muscle invasive bladder cancer.</p><p>BioCryst Pharmaceuticals (BCRX) shares were up more than 2% after the company said the US Food and Drug Administration approved Orladeyo oral pellets to help prevent hereditary angioedema attacks in children ages 2 to under 12.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2590047895","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590047895","pubTimestamp":1765549108,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were edging higher premarket Friday, with the State Street Health Care Select Sector SPDR ETF  advancing by 0.6% and the iShares Biotechnology ETF  up 0.1%.Relay Therapeutics  shares were up more than 11% after the company said interim results from a study of zovegalisib plus fulvestrant to treat breast cancer patients showed \"robust activity.\"ImmunityBio  stock was up more than 4% after the company said the European Medicines Agency has recommended granting a conditional marketing authorization for anktiva in combination with BCG for the treatment of BGC-unresponsive non-muscle invasive bladder cancer.BioCryst Pharmaceuticals  shares were up more than 2% after the company said the US Food and Drug Administration approved Orladeyo oral pellets to help prevent hereditary angioedema attacks in children ages 2 to under 12.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BCRX":"BioCryst制药","BK4588":"碎股","RLAY":"Relay Therapeutics","BK4581":"高盛持仓","BK4585":"ETF&股票定投概念","LABU":"三倍做多标普生物-Direxion","IBB":"生物科技指数ETF-iShares Nasdaq","XLV":"健康照护类股ETF-SPDR","IBRX":"ImmunityBio, Inc.","XBI":"SPDR S&P Biotech ETF","BK4547":"WSB热门概念","BK4563":"昨日强势股"},"translate_title":"行业更新：医疗保健股周五盘前小幅走高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BCRX":1,"IBRX":1,"XLV":1,"IBB":1,"XBI":0.6,"RLAY":1,"LABU":0.6},"content_text":"Health care stocks were edging higher premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.6% and the iShares Biotechnology ETF (IBB) up 0.1%.Relay Therapeutics (RLAY) shares were up more than 11% after the company said interim results from a study of zovegalisib plus fulvestrant to treat breast cancer patients showed \"robust activity.\"ImmunityBio (IBRX) stock was up more than 4% after the company said the European Medicines Agency has recommended granting a conditional marketing authorization for anktiva in combination with BCG for the treatment of BGC-unresponsive non-muscle invasive bladder cancer.BioCryst Pharmaceuticals (BCRX) shares were up more than 2% after the company said the US Food and Drug Administration approved Orladeyo oral pellets to help prevent hereditary angioedema attacks in children ages 2 to under 12.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590047895","isCrawlerRequest":true}